Ability of the endocrine pancreas to attenuate the increase of plasma potassium caused by succinylcholine.
D000200:Action Potentials; D000768:Anesthesia, General; D000818:Animals; D004285:Dogs; D005260:Female; D007328:Insulin / Q000378:metabolism / Q000502:physiology*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism / Q000502:physiology*; D007545:Isoproterenol; D008297:Male; D009020:Morphine; D009132:Muscles / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects / Q000502:physiology; D010180:Pancreatectomy; D010424:Pentobarbital; D011188:Potassium / Q000097:blood*; D013390:Succinylcholine / Q000494:pharmacology*
D007328:Insulin; D009020:Morphine; D010424:Pentobarbital; D013390:Succinylcholine; D007545:Isoproterenol; D011188:Potassium